Amy

Kennedy

MD

MS

Education & Training

• MD, high honors, University of Washington, Seattle, WA (2010–2014)
• Residency in Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA (2014–2017)
• Chief Resident in Internal Medicine, University of Pittsburgh, Pittsburgh, PA (2017–2018)
• MS, Clinical Research, University of Pittsburgh, Pittsburgh, PA (2018–2020)
• Clinician Researcher Fellow, University of Pittsburgh, Pittsburgh, PA (2018–2020)

Honors

• Fellow, American Society of Addiction Medicine (2021)
• University of Pittsburgh Medical Center Medical Education Plenary Award (2018)
• First Place Research Poster, University of Pittsburgh Internal Medicine Research Day (2017)
• Thomas O’Toole Senior Resident Award for “Outstanding Care for Vulnerable Populations” (2017)
• Society for Pediatric Pathology Gilbert-Barness Award (2014)
• Wyoming Medical Society Outstanding Graduate Scholarship Award (2014)
• Alpha Omega Alpha (AOA) Honor Society, University of Washington (2013)
• Gold Humanism Honor Society, University of Washington (2013)

Research & Clinical Interests 

• Curricular development for addiction medicine within graduate medical education
• Implementation of evidence-based treatment of substance use disorders within primary care
• Low-barrier access to medications for addiction treatment
• Primary care for people experiencing homelessness
• Primary care for people living with HIV
• Treatment of substance use disorders

publication highlights

• Kennedy AJ, McNeil M, Hamm M, de Abril Cameron F, Carter A. Internal Medicine Resident Perceptions of Patients with Substance Use Disorder After Attending a Mutual Support Group Meeting. Journal of General Internal Medicine; 29 Oct 2019, 35(3):918-921.
• Kennedy AJ, Bakalov V, Reyes-Uribe L, Kensler C, Connor S, Bui T, Radomski T. Free Clinic Patients’ Perceptions and Barriers to Applying for Health Insurance After Implementation of the Affordable Care Act. Journal of Community Health; 2020; 45: 492-500.
• Kennedy AJ, de April Cameron F, Hassan I, Goabo V, Fisk S, Ho K, Edelman J, Hamm M, Merlin J. Barriers and Facilitators to Providing HIV Pre-Exposure Prophylaxis among Buprenorphine Prescribers: A Qualitative Study.  Journal of Addiction Medicine. September 8, 2020. Volume published ahead of print.
• Kennedy AJ, Lombardi K, Fruehstorfer G, Hamm M, McNeil M, Carter A. Words Medicine Residents Use to Describe Substance Use Disorders After Attending a Mutual Support Group Meeting. Journal of General Internal Medicine. January 6, 2021.
• Kennedy AJ, Wessel CB, Levine R, Downer K, Raymond M, Osakue D, Hassan I, Merlin JS, Liebschutz JM. Factors Associated with Long-term Retention in Buprenorphine-Based Addiction Treatment Programs: A Systematic Review. Journal of General Internal Medicine. January 19, 2021. Online ahead of print.
• Kennedy AJ, McGinnis KA, Merlin JS, Edelman EJ, Gordon AJ, Korthuis PT, Skanderson M, Williams EC, Wyse J, Oldfield B, Bryant K, Justice A, Fiellin D, Kraemer KL. Impact of intensity of behavioral treatment, with and without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV. Journal of Substance Abuse and Treatment. 2021 May 29;132:108509
• Paul N, Kennedy AJ, Taubenberger S, Chang JC, Hacker K. Provider Perceptions of Medication for Opioid Use Disorder (MOUD) in Allegheny County Pennsylvania. Substance Abuse Journal. In Press. 2021.